Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
about
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapyBarriers to a cure for HIV in womenPreconception and contraceptive care for women living with HIVAntiretroviral pharmacology in mucosal tissuesCare of the HIV-infected pregnant woman in the developed worldHIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077Clinical parameters essential to methodology and interpretation of mucosal responsesHIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.The Role of Caveolin 1 in HIV Infection and Pathogenesis.Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocolThe effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.Mucosal immunity in the female genital tract, HIV/AIDSHIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.Dilemma of concepts and strategies for the prevention of spread of HIV in relation to human behavior, law and human rights.A prospective cohort study of the effect of depot medroxyprogesterone acetate on detection of plasma and cervical HIV-1 in women initiating and continuing antiretroviral therapy.Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex.Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV InfectionAdherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok.Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV sheddingExamining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice.Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.Measuring the latent reservoir in vivo.Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan womenEvaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.Unsafe Sex and STI Prevalence Among HIV-Infected Adults in Guangzhou, China: Opportunities to Deamplify Sexual HIV Transmission.Antiviral agents and HIV prevention: controversies, conflicts, and consensus.HIV-1 treatment as prevention: the good, the bad, and the challenges.Implementation of a safer conception service for HIV-affected couples in South Africa
P2860
Q22251085-748F8424-6A65-4CE7-93F3-2D460D453D2AQ26768632-6DF6F529-99F8-4E90-9534-647EE87EED0FQ27012918-847F41C4-AAE5-4BC8-8A72-C9B9E3ABA2F1Q27014675-290C9105-DDB9-4EC7-ACC4-662F05B1CF20Q28082774-068610B3-117D-4AE5-9A6B-DD68DD6DDB39Q28541918-7FD4B42E-81E8-4BE0-96FC-84CCFCFDCEC4Q30398452-54E91595-EE37-4541-8A10-E53E5400D97FQ31130557-14E737AF-BCDB-4243-A39B-A7466FD6DF1FQ32183747-B7DABF4C-E64D-490A-8C18-980ADB6A08B6Q33390618-497706B9-CDF8-4636-8E60-F42572AE3CAEQ33798584-5D3E3795-F139-40CD-B3AE-BA1E138DBE1BQ33916922-4E199736-E471-4E94-9EDB-7314ABE21AEBQ33988160-FE7DF8CE-8D85-4879-BFAB-AC91F5535E14Q34275424-61327C1A-A7EB-43B5-966B-F69EE706EF94Q34366639-7526928B-FC07-4D44-B397-C199C97B360FQ35051376-EC797706-CB36-44D7-AA16-85090B83F401Q35100857-48311835-448D-4BE5-AFC1-EAEB584A0EF1Q35569646-6149F1DA-6B61-40A0-A186-E86F5337A19CQ35606068-DC47202C-729E-4487-A902-F348084111CCQ35641764-27663347-9953-4B41-9815-5AB215B8073FQ35706820-C100B9A6-8931-46FA-B186-2079803A1F2CQ35750861-6B0F4C96-1587-4F69-AE56-0C591F76381DQ35810259-1177CF72-2837-4532-A8A5-380A5DA083C0Q35821254-7CA1D699-6D84-44E8-80AD-EFA755FD7AFBQ35906707-7381E3D5-59C8-417A-AFAE-F0537DDCEB77Q35962509-E7D47BC2-BBBE-4AEF-9655-6BFD792048E6Q36086387-E1A016BC-D884-431E-8FB2-4577831B3DF9Q36161438-B757B816-9D67-41C2-B856-BC74C75939EEQ36343568-2128DDC7-F4B9-4310-A2AF-51AF877C7EA0Q36358905-76B12144-E7C5-4121-B65F-3B53EF0F1D7DQ36389094-57C85463-4F35-487F-A1DA-F16B1CFB05D3Q36509620-B9A602BA-0FC1-4092-8FCE-502805D484C3Q36515110-3118F314-0F97-416E-8E9E-71D64ADC20C6Q36545289-72F7DE30-EE27-4F14-BB0D-B1F57C424B91Q36734872-20BB62B7-9A5E-48DC-B90C-4421E15C5F88Q36768992-1F7D55AE-352B-48E0-8BDE-4F0175C9FEEAQ36792612-863F774C-A645-46CB-96E9-71E9DAAB2B38Q36836680-A11667E1-49B3-4C1B-8802-85110FDF68A3Q36883784-16920E69-7B41-43F3-B193-6A16DF4C6E6BQ36941225-62426FD8-06E5-4428-A392-3D09AABA69E7
P2860
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@en
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@nl
type
label
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@en
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@nl
prefLabel
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@en
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@nl
P2093
P1433
P1476
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
@en
P2093
Allison K DeLong
Angela M Caliendo
Jaclynn Kurpewski
Jessica Ingersoll
Kartik K Venkatesh
Maria Pia De Pasquale
Richard D'Aquila
Susan Cu-Uvin
P304
P356
10.1097/QAD.0B013E32833E5043
P407
P50
P577
2010-10-01T00:00:00Z